Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF (REDES-TNF)

This study has been completed.
Sponsor:
Collaborator:
Spanish reumatology Society
Information provided by (Responsible Party):
Dra. Caridad Pontes, Spanish Clinical Pharmacology Society
ClinicalTrials.gov Identifier:
NCT01604629
First received: May 17, 2012
Last updated: November 16, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)